Get started
Author

Guillermo Arreaza

Observed names: G A Arreaza, G ARREAZA, G Arreaza, G. A. Arreaza, G. Arreaza, G.A. Arreaza, GUILLERMO A. ARREAZA, GUILLERMO ARREAZA, Guillermo A Arreaza, Guillermo A. Arreaza
OpenAlex ID: A5110335106
Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes
2001 · Shayan Sharif, Guillermo A. Arreaza, et al. · Nature Medicine · 611
IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function
1997 · M J Cameron, G A Arreaza, et al. · The Journal of Immunology · 227
Differential Expression of CC Chemokines and the CCR5 Receptor in the Pancreas Is Associated with Progression to Type I Diabetes
2000 · Mark J Cameron, Guillermo A Arreaza, et al. · The Journal of Immunology · 142
Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.
1997 · G A Arreaza, M J Cameron, et al. · Journal of Clinical Investigation · 82
PDF
Insulin B-chain reactive CD4+ regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells.
1999 · I Bergerot, G A Arreaza, et al. · Diabetes · 70
Impaired Plasma Membrane Targeting of Grb2–Murine Son of Sevenless (mSOS) Complex and Differential Activation of the Fyn–T Cell Receptor (TCR)-ζ–Cbl Pathway Mediate T Cell Hyporesponsiveness in Autoimmune Nonobese Diabetic Mice
1997 · Konstantin Salojin, Jian Zhang, et al. · The Journal of Experimental Medicine · 65
PDF
Long-term Outcomes With Islet-Alone and Islet-After-Kidney Transplantation for Type 1 Diabetes in the Clinical Islet Transplantation Consortium: The CIT-08 Study
2022 · Michael R. Rickels, Thomas L. Eggerman, et al. · Diabetes Care · 55
PDF
Regulation of autoimmune disease by natural killer T cells
2002 · Shayan Sharif, Guillermo A. Arreaza, et al. · Journal of Molecular Medicine · 54
Regulatory Natural Killer T Cells Protect against Spontaneous and Recurrent Type 1 Diabetes
2002 · SHAYAN SHARIF, GUILLERMO A. ARREAZA, et al. · Annals of the New York Academy of Sciences · 47
Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer
2000 · M J Cameron, G A Arreaza, et al. · Gene Therapy · 46
Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism
2010 · Craig Meagher, Josh Beilke, et al. · Diabetes · 45
PDF
Deficient activation and resistance to activation-induced apoptosis of cd8+ t cells is associated with defective peripheral tolerance in nonobese diabetic mice
2003 · Guillermo Arreaza, Konstantin Salojin, et al. · Clinical Immunology · 39
CCL4 Protects From Type 1 Diabetes by Altering Islet β-Cell–Targeted Inflammatory Responses
2007 · Craig Meagher, Guillermo Arreaza, et al. · Diabetes · 38
PDF
The Use of the Severe Combined Immunodeficient Mouse and the Athymic "Nude" Mouse as Models for the Study of Human Autoimmune Thyroid Disease
1993 · Robert Volpé, Yoshio Kasuga, et al. · Clinical Immunology and Immunopathology · 31
Biolistic-Mediated Interleukin 4 Gene Transfer Prevents the Onset of Type 1 Diabetes
2000 · Mark J. Cameron, Craig A. Strathdee, et al. · Human Gene Therapy · 27
Seroreactivity to Bacterial Antigens Is Not a Unique Phenomenon in Patients with Autoimmune Thyroid Diseases in Canada
1994 · ERIKA RESETKOVA, ROBERT NOTENBOOM, et al. · Thyroid · 25
Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice
1994 · N Yoshikawa, G Arreaza, et al. · The Journal of Clinical Endocrinology & Metabolism · 24
Antibody to gp39, the Ligand for CD40 Significantly Inhibits the Humoral Response from Graves' Thyroid Tissues Xenografted into Severe Combined Immunodeficient (SCID) Mice
1996 · ERIKA RESETKOVA, KEISUKE KAWAI, et al. · Thyroid · 23
Studies of thyroid xenografts from Graves' disease in severe combined immunodeficient mice
1993 · T Morita, N Yoshikawa, et al. · The Journal of Clinical Endocrinology & Metabolism · 23
Cytokines and Chemokines in the Pathogenesis of Murine Type 1 Diabetes
2003 · C. Meagher, S. Sharif, et al. · Advances in experimental medicine and biology · 22
Role of T-cell anergy and suppression in susceptibility to IDDM
1997 · I. Bergerot, G. Arreaza, et al. · Research in Immunology · 19
Expression of intercellular adhesion molecule-1 on human thyroid cells from patients with autoimmune thyroid disease: study of thyroid xenografts in nude and severe combined immunodeficient mice and treatment with FK-506
1995 · G Arreaza, N Yoshikawa, et al. · The Journal of Clinical Endocrinology & Metabolism · 18
New Animal Models for Human Autoimmune Thyroid Disease
1993 · R. Volpé, F. Akasu, et al. · Hormone and Metabolic Research · 15
Activation of T lymphocyte subsets by synthetic TSH receptor peptides and recombinant glutamate decarboxylase in autoimmune thyroid disease and insulin-dependent diabetes
1995 · T Mukuta, N Yoshikawa, et al. · The Journal of Clinical Endocrinology & Metabolism · 11
Role of Regulatory T Cells in the Pathogenesis of Autoimmune Diabetes
2001 · G.A. Arreaza, S. Sharif, et al. · KARGER eBooks · 7
Works count: 40
Citation count: 1,814
H-index: 20
I10-index: 24
Year
Topic
Type